Biogen (NASDAQ:BIIB) Given Hold Rating at Needham & Company LLC
Biogen (NASDAQ:BIIB – Get Free Report)‘s stock had its “hold” rating reiterated by equities research analysts at Needham & Company LLC in a research report issued to clients and investors on Thursday,Benzinga reports. Other equities analysts also recently issued reports about the stock. Citigroup cut their price target on shares of Biogen from $190.00 to […]
Biogen (NASDAQ:BIIB – Get Free Report)‘s stock had its “hold” rating reiterated by equities research analysts at Needham & Company LLC in a research report issued to clients and investors on Thursday,Benzinga reports. Other equities analysts also recently issued reports about the stock. Citigroup cut their price target on shares of Biogen from $190.00 to […]
